PUYALLUP, Wash., March 20, 2017 /PRNewswire/ -- Western Institutional Review Board® (WIRB™), the world's leading provider of ethical review of clinical research, announced today the launch of its WIRB NIH Single Review SolutionTM (SRS) for NIH-funded multi-site research. As the long-standing leader in supporting IRB reviews among its 2,300 institution clients, WIRB has an extensive background in reviewing clinical trials funded by NIH. Building upon our trusted status as the IRB of record for the majority of institutions that conduct clinical research in the US, our WIRB NIH Single Review Solution will provide participating institutions the gold standard of research review that has made WIRB the trusted leader to institutions for over 40 years.
Starting in September of 2017, NIH's new policy directing a Single Review Mandate for multicenter clinical trials becomes effective. This mandate applies to research funded by NIH and is intended to improve the overall efficiency of managing clinical research grants. The WIRB NIH Single Review Solution assures that participating institutions will comply with the requirements of the NIH Single Review Mandate without the expense and challenges of establishing a central IRB. The advantages of this affordable and easy-to-implement solution includes: WIRB review and oversight, coordination of site submissions and vital communications, accurate budgeting for IRB review of multi-year studies, all accompanied by the support of our review professionals who will ease the administrative burdens on your study staff by providing the necessary coordination and communication with all of the participating sites. WIRB has combined the trusted track record of its people, process, and technology, in providing one solution to make it less burdensome for investigators and institutions to plan, submit, and conduct their NIH-funded studies as efficiently, compliantly, and safely as possible.